[Acute embolic myocardial infarction complicating bioprosthetic stentless aortic valve endocarditis].
We describe the case of bioprosthetic stentless aortic valve endocarditis due to Staphylococcus epidermidis in a female patient, who previously underwent mitral and aortic valve replacement: she presented left main coronary artery occlusion due to septic embolus with subsequent myocardial infarction complicated by cardiogenic shock. We discuss the therapeutic strategies, both medical and interventional, and the surgical options.
Brambilla
Gabriella
G
U.O. di Cardiologia Riabilitativa Fondazione Don Gnocchi ONLUS Via Capecelatro, 66 20148 Milano. cardiologia@dongnocchi.it
Ferratini
Maurizio
M
Heyman
Joanna
J
Racca
Vittorio
V
Danna
Paolo
P
Lemma
Massimo
M
Antona
Carlo
C
D000900:Anti-Bacterial Agents / Q000627:therapeutic use; D001021:Aortic Valve; D001705:Bioprosthesis; D017023:Coronary Angiography; D003331:Coronary Vessels; D017548:Echocardiography, Transesophageal; D004617:Embolism / Q000150:complications*; D004697:Endocarditis, Bacterial / Q000150:complications* / Q000175:diagnosis / Q000188:drug therapy; D005260:Female; D006350:Heart Valve Prosthesis; D019918:Heart Valve Prosthesis Implantation; D006801:Humans; D008875:Middle Aged; D008943:Mitral Valve; D009203:Myocardial Infarction / Q000175:diagnosis / Q000209:etiology*; D013902:Radiography, Thoracic; D013203:Staphylococcal Infections / Q000150:complications* / Q000175:diagnosis / Q000188:drug therapy; D013212:Staphylococcus epidermidis / Q000302:isolation & purification
D000900:Anti-Bacterial Agents